Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 17Phase 1 11Phase 1/2 7Phase 3 5Phase 4 4

Status

Recruiting 2Completed 2Unknown 1

Sponsor Class

OTHER 5INDUSTRY 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 551Colorectal Neoplasms 246Neoplasms 232Prostatic Neoplasms 221Carcinoma, Non-Small-Cell Lung 196Stomach Neoplasms 153Leukemia, Myeloid, Acute 149Carcinoma, Hepatocellular 147Lung Neoplasms 136Rectal Neoplasms 135Multiple Myeloma 132Nasopharyngeal Carcinoma 111Colonic Neoplasms 106Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Lymphoma 85Uterine Cervical Neoplasms 83Pancreatic Neoplasms 82Lymphoma, Large B-Cell, Diffuse 79Ovarian Neoplasms 78Leukemia 78Head and Neck Neoplasms 77Esophageal Neoplasms 74Lymphoma, Follicular 72Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 65Recurrence 64Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 58Pain 56

Interventions

capivasertib 1Temozolomide 1Radiotherapy 1Lenalidomide 1Gemcitabine 1Etoposide 1Cisplatin 1Carboplatin 1Bortezomib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Disease Progression × Clear all
NCT01191060 2026-04-06

IFM/DFCI2009

University Hospital, Toulouse

Phase 3 Completed
700 enrolled
Plasma cell

Disease Progression, Neoplasms, Plasma Cell

NCT07281833 2026-02-27

CAPIcorn

West German Study Group

Phase 3 Recruiting
250 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT07008716 2025-06-06

Omitting CTV for Primary Tumor in LS-SCLC

Sun Yat-sen University

Phase 3 Recruiting
852 enrolled

Radiation Injuries, Disease Progression

NCT02761070 2023-03-08

RE-GEND

Kyorin University

Phase 3 Unknown
146 enrolled
CNS

Glioblastoma, Recurrence, Disease Progression

NCT00102414 2006-11-14

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

AGO Study Group

Phase 3 Completed
356 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡